United States News Todas as matérias

Arcus Biosciences (NYSE:RCUS) has announced a new clinical trial collaboration and supply agreement with Bristol Myers Squibb (NYSE:BMY) aimed at advancing treatment options for advanced renal cell carcinoma (RCC).

Treasure Global (NASDAQ:TGL) has unveiled its preliminary outlook for fiscal year 2026, forecasting revenue growth in excess of 100% on a year-over-year basis.

Avalyn Pharma (NASDAQ:AVLN) provided a comprehensive update on its financial position and clinical development programs for the first quarter of 2026, underscored by a strengthened capital base following its recent initial public offering.

Rent the Runway (NASDAQ:RENT) delivered a strong start to the fiscal year, reporting first-quarter revenue that outpaced corporate guidance even as the company moves through a high-level executive transition.

Accel Entertainment (NYSE:ACEL) announced that its subsidiary, Toucan Gaming, has acquired the assets of Rice Palace and South Louisiana Gaming, the owner and operator of the Rice Palace Truck Stop Casino.

TG Therapeutics (NASDAQ:TGTX) announced positive data from a Phase 1 clinical trial evaluating a high-concentration subcutaneous formulation of its multiple sclerosis therapy Briumvi (ublituximab-xiiy).

Wellington Management has signed a definitive agreement to acquire Hartford Funds from insurer The Hartford Financial Services Group (NYSE:HIG), a transaction that structurally consolidates a 40-year sub-advisory alliance into a unified asset management platform.

Axsome Therapeutics (NASDAQ:AXSM) has resolved all outstanding U.S. patent litigation concerning its sleep disorder medication, Sunosi, securing the drug's proprietary market positioning for nearly another two decades.

Sprinklr (NYSE:CXM) reported top-line expansion and a successful shift into GAAP operational profitability for its fiscal first quarter ended April 30, 2026, capitalising on continuous adoption of its unified customer experience management platform.

Destination XL Group (NASDAQ:DXLG) reported a 2.1% decline in sales for the first quarter of fiscal 2026 as the specialty retailer navigates a challenging consumer environment, while doubling down on digital and fit-technology initiatives.

Old Dominion Freight Line (NASDAQ:ODFL) reported a 12.3% increase in revenue per day for May 2026 compared with the same month last year, driven by robust pricing gains that overrode lower volume metrics.

Cognyte Software (NASDAQ:CGNT) delivered double-digit revenue growth and a sharp improvement in core operational profitability for the first quarter of fiscal 2027, capitalising on sustained global demand for its security and investigative analytics software platforms.

VersaBank (NASDAQ:VBNK) reported strong growth in its underlying lending operations for the second quarter of fiscal 2026, driven by a sustained expansion of its credit assets across North American markets.

Ollie’s Bargain Outlet Holdings (NASDAQ:OLLI) reported strong financial results for the first quarter of fiscal 2026, driven by double-digit sales growth, substantial margin expansion, and an aggressive build-out of its physical store footprint.

Macy’s (NYSE:M) reported an increase in first-quarter profitability and sales, lifted by strong luxury performance at Bloomingdale’s and positive momentum across its core turnaround properties.

MiniMed (NASDAQ:MMED) reported a 15.6% increase in fourth-quarter net sales to $837 million, closing out a record-setting fiscal year 2026 driven by strong international adoption and rising attachment rates for its continuous glucose monitoring (CGM) technologies.

Medtronic (NYSE:MDT) reported a 9.9% increase in fourth-quarter revenue to $9.8 billion, closing out its fiscal year 2026 with broad-based operational momentum across its core therapeutic portfolios.

Miami International Holdings (NYSE:MIAX) reported sharp volume expansion across its options exchanges for May 2026, driven by an influx of retail and institutional derivatives trading that lifted the firm’s total market footprint.

Parsons (NYSE:PSN) has secured a new $28 million task order from the U.S. Air Force to provide advanced software lifecycle support and system integration, reinforcing its position as a key technology provider for national security initiatives.

Thor Industries (NYSE:THO) reported a drop in fiscal third-quarter profit and revenue, prompting the recreational vehicle manufacturer to lower its full-year earnings expectations.

MannKind (NASDAQ:MNKD) achieved key clinical development milestones for its investigational lung disease therapy, pushing its dry powder formulation of nintedanib further into mid-stage clinical testing.

KBR (NYSE:KBR) announced that its Mission Technology Solutions unit has been awarded a landmark $8 billion ceiling contract by the U.S. National Science Foundation (NSF) to provide comprehensive science and engineering support for the U.S. Antarctic Program.

T1 Energy (NYSE:TE) has entered into a definitive agreement to acquire KORE Power for an aggregate enterprise value of approximately $32 million, securing a specialized foothold in the rapidly expanding utility-scale energy storage sector.

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical collaboration agreement with Swiss healthcare giant Roche to evaluate a novel combination therapy aimed at a genetically distinct and difficult-to-treat form of pancreatic cancer.